 |
Ciara Curtin is GenomeWeb's science features editor as well as the editor of the Daily Scan and Careers blogs. E-mail Ciara Curtin and follow @DailyScan, and @CareersGW on Twitter. |
RNAi Screen Finds Potential Huntington's Disease Drug Targets
November 30, 2012
RNAi Screen Finds Potential Huntington's Disease Drug Targets
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Isis, Roche Partner on Huntington’s Disease Drug Program
April 11, 2013 / Gene Silencing News - UniQure Enters RNAi Field with Benitec Cross-Licensing Deal
December 6, 2012 / Gene Silencing News - UT Southwestern Team Publishes Details on Duplex RNA Inhibition of Huntington's Disease Gene
October 18, 2012 / Gene Silencing News - Alnylam Steps Back from Huntington's Drug Deal, Sees Two Partnerships by Year-End
May 10, 2012 / Gene Silencing News - Alnylam Presents Clinical Data from Cholesterol Drug Trial, Animal Data from Huntington's Program
January 5, 2012 / Gene Silencing News